Cover Image
市場調查報告書

體外式薄膜型人工肺 (ECMO) 系統的全球市場的預測 ∼2021年:模式 (VA、VV、AV)、用途 (呼吸系統、心臟、ECPR)、各地區分析

Extracorporeal Membrane Oxygenation (ECMO) Machine Market [By Modality {Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)}, By Application {Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)}] Analysis & Forecasts to 2021

出版商 MarketsandMarkets 商品編碼 347366
出版日期 內容資訊 英文 131 Pages
訂單完成後即時交付
價格
Back to Top
體外式薄膜型人工肺 (ECMO) 系統的全球市場的預測 ∼2021年:模式 (VA、VV、AV)、用途 (呼吸系統、心臟、ECPR)、各地區分析 Extracorporeal Membrane Oxygenation (ECMO) Machine Market [By Modality {Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)}, By Application {Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)}] Analysis & Forecasts to 2021
出版日期: 2017年02月27日 內容資訊: 英文 131 Pages
簡介

全球體外式薄膜型人工肺 (ECMO) 設備的市場,2016年達到了2億4,720萬美元的規模。從2016年到2021年預計以4.3%的年複合成長率發展,2021年成長到3億530萬美元的規模。這個成長的背景中,有提高循環系統系疾病及呼吸疾病增加,肺移植中介的ECMO的引進增加,ECMO中心數的增加,為提高認知的會議和進修計劃的增加及技術的進步等要素。

本報告提供全球體外式薄膜型人工肺 (ECMO) 系統的市場相關調查,相關的疾病和系統概要,市場成長的各種推動因素、阻礙要素及市場機會分析,各模式、用途、地區/主要國家的主要趨勢及市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 簡介
  • 市場動態
    • 成長推動因素
    • 阻礙要素
    • 機會
    • 課題

第6章 市場分析:各種模式

  • 簡介
  • 靜脈、靜脈 (VV) 方式
  • 靜脈、動脈 (VA) 方式
  • 動脈、靜脈 (AV) 方式

第7章 市場分析:各用途

  • 簡介
  • 呼吸系統
    • 新生兒
    • 小兒科
    • 成人
  • 心臟
    • 成人
    • 小兒科
    • 新生兒
  • 體外循環式心肺甦醒 (ECPR)
    • 新生兒
    • 小兒科
    • 成人

第8章 地區分析

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他

第9章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭情形及趨勢
    • 核准
    • 新產品的開發、投入
    • 協定、聯盟
    • 擴張
    • 其他策略

第10章 企業簡介

  • 簡介
  • GETINGE GROUP
    • 產業概要
    • 產品
    • 發展趨勢
    • MNM的見解等
  • MEDTRONIC PLC
  • LIVANOVA PLC
  • Terumo Corporation
  • XENIOS AG (ACQUIRED BY FRESENIUS MEDICAL CARE AG & CO. KGAA
  • MICROPORT SCIENTIFIC CORPORATION
  • Nipro
  • ORIGEN BIOMEDICAL, INC.
  • ALUNG TECHNOLOGIES, INC.
  • EUROSETS S.R.L.

第11章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MD 3966

The extracorporeal membrane oxygenation (ECMO) machine market is poised to reach USD 305.3 million by 2021 from USD 247.2 million in 2016, at a CAGR of 4.3%. Factors such as growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to lung transplantation, growing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements have led to the growth of the market.

On the basis of modality, the market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The venovenous (VV) segment is expected to account for the largest share of the market in 2016. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, and technological advancements. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the forecast period.

Based on application, the respiratory segment is expected to account for the largest share of the market, in 2016. The large share of this segment is mainly attributed to factors such as rising incidence of respiratory failure, lung cancer, growing lung transplants, and increasing adoption of ECMO systems.

North America is expected to account for the largest share of the global market in 2016, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). The large share of the North American region can be attributed to the favorable reimbursement scenario, the rising incidence of lung cancer, and the presence of a large number of ECMO centers in the U.S.

The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the favorable reimbursement scenario in Japan, the rising cardiovascular diseases in China, the growing application and adoption of ECMO in India, and the rising cardiopulmonary disorders in Australia.

The market witnesses high competitive intensity, as there are several big and small firms with similar product offerings. These companies adopt various strategies (approvals, product launches, agreements & partnerships, expansions, rebranding, acquisitions, website launches, product deployments, and market development) to increase their market shares and establish a stronger foothold in the global market.

Research Coverage:

This report studies the ECMO machine market based on modality, application, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them, garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies to strengthen their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the ECMO machine market. The report analyzes the market based on modality, application, and region.
  • Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the ECMO machine market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various Extracorporeal Membrane Oxygenation (ECMO) products across regions.
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the ECMO machine market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the ECMO machine market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
      • 2.2.1.1. Key data from secondary sources
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key insights from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE: MARKET OVERVIEW
  • 4.2. GEOGRAPHIC ANALYSIS: ECMO MACHINE MARKET, BY MODALITY (2016)
  • 4.3. ECMO MACHINE MARKET, BY APPLICATION, 2016KKKKK VS. 2021
  • 4.4. GEOGRAPHIC SNAPSHOT OF THE ECMO MACHINE MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Increasing prevalence of cardiovascular and respiratory diseases
      • 5.2.1.2. Growing adoption of ECMO in lung transplantation procedures
      • 5.2.1.3. Growth in the number of ECMO centers
      • 5.2.1.4. Technological advancements in ECMO machine
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Complications associated with ECMO
      • 5.2.2.2. High cost of ECMO procedures
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Increasing survival rates with ECMO
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Lack of skilled professionals

6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET, BY MODALITY

  • 6.1. INTRODUCTION
  • 6.2. VENOVENOUS ECMO
  • 6.3. VENOARTERIAL ECMO
  • 6.4. ARTERIOVENOUS ECMO

7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET, BY APPLICATION

  • 7.1. INTRODUCTION
  • 7.2. RESPIRATORY APPLICATIONS
    • 7.2.1. NEONATES
    • 7.2.2. PEDIATRICS
    • 7.2.3. ADULTS
  • 7.3. CARDIAC APPLICATIONS
    • 7.3.1. ADULTS
    • 7.3.2. PEDIATRICS
    • 7.3.3. NEONATES
  • 7.4. EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR)
    • 7.4.1. NEONATES
    • 7.4.2. PEDIATRICS
    • 7.4.3. ADULTS

8. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET, BY REGION

  • 8.1. INTRODUCTION
  • 8.2. NORTH AMERICA
    • 8.2.1. U.S.
      • 8.2.1.1. Rising healthcare spending
      • 8.2.1.2. Rise in geriatric population, prevalence of cardiovascular diseases
      • 8.2.1.3. Increase in research studies
    • 8.2.2. CANADA
      • 8.2.2.1. Implementation of a new funding model in Canadian hospitals
      • 8.2.2.2. Conferences to increase awareness
  • 8.3. EUROPE
    • 8.3.1. GERMANY
      • 8.3.1.1. Increasing volume of ECMO procedures in Germany
    • 8.3.2. U.K.
      • 8.3.2.1. Rising adoption of ECMO procedures
    • 8.3.3. FRANCE
      • 8.3.3.1. Rising healthcare spending
    • 8.3.4. REST OF EUROPE
      • 8.3.4.1. Decreasing number of cardiovascular deaths in Spain
      • 8.3.4.2. Rising risk of diseases in Sweden
  • 8.4. ASIA-PACIFIC
    • 8.4.1. JAPAN
      • 8.4.1.1. Favorable reimbursement scenario
    • 8.4.2. CHINA
      • 8.4.2.1. Rising geriatric population, CVD prevalence
    • 8.4.3. INDIA
      • 8.4.3.1. Growing applications and rising adoption of ECMO
    • 8.4.4. REST OF ASIA-PACIFIC
      • 8.4.4.1. Prevalence of cardiovascular and respiratory diseases in Australia
  • 8.5. REST OF THE WORLD
      • 8.5.1.1. Rising adoption of ECMO as a bridge to heart and lung transplantation in Brazil
      • 8.5.1.2. Conferences in UAE to increase awareness

9. COMPETITIVE LANDSCAPE

  • 9.1. OVERVIEW
  • 9.2. MARKET SHARE ANALYSIS
    • 9.2.1. GETINGE GROUP
    • 9.2.2. MEDTRONIC PLC
    • 9.2.3. LIVANOVA PLC
  • 9.3. COMPETITIVE SITUATION AND TRENDS
    • 9.3.1. APPROVALS
    • 9.3.2. PRODUCT LAUNCHES
    • 9.3.3. AGREEMENTS & PARTNERSHIPS
    • 9.3.4. EXPANSIONS
    • 9.3.5. OTHER STRATEGIES

10. COMPANY PROFILES (Company overview, Product offerings, Recent developments)*

  • 10.1. INTRODUCTION
  • 10.2. GETINGE GROUP
  • 10.3. MEDTRONIC PLC
  • 10.4. LIVANOVA PLC
  • 10.5. TERUMO CORPORATION
  • 10.6. XENIOS AG (ACQUIRED BY FRESENIUS MEDICAL CARE AG & CO. KGAA)
  • 10.7. MICROPORT SCIENTIFIC CORPORATION
  • 10.8. NIPRO CORPORATION
  • 10.9. ORIGEN BIOMEDICAL, INC.
  • 10.10. ALUNG TECHNOLOGIES, INC.
  • 10.11. EUROSETS S.R.L.

*Details on Company overview, Product offerings, Recent developments might not be captured in case of unlisted companies.

11. APPENDIX

  • 11.1. DISCUSSION GUIDE
  • 11.2. OTHER DEVELOPMENTS
    • 11.2.1. LIVANOVA PLC
    • 11.2.2. XENIOS AG (ACQUIRED BY FRESENIUS MEDICAL CARE AG & CO. KGAA)
    • 11.2.3. ALUNG TECHNOLOGIES, INC.
  • 11.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • 11.4.1. FEATURES AND BENEFITS OF RT:
  • 11.5. AVAILABLE CUSTOMIZATIONS
  • 11.6. RELATED REPORTS
  • 11.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: AVERAGE COST OF ECMO IN VARIOUS COUNTRIES
  • TABLE 2: INDICATIVE LIST OF TRAINING PROGRAMS FOR ECMO BY HOSPITALS
  • TABLE 3: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 4: VENOVENOUS ECMO MACHINE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: NORTH AMERICA: VENOVENOUS ECMO MACHINE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 6: EUROPE: VENOVENOUS ECMO MACHINE MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 7: ASIA-PACIFIC: VENOVENOUS ECMO MACHINE MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 8: VENOARTERIAL ECMO MACHINE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: NORTH AMERICA: VENOARTERIAL ECMO MACHINE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: EUROPE: VENOARTERIAL ECMO MACHINE MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 11: ASIA-PACIFIC: VENOARTERIAL ECMO MACHINE MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 12: ARTERIOVENOUS ECMO MACHINE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: NORTH AMERICA: ARTERIOVENOUS ECMO MACHINE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: EUROPE: ARTERIOVENOUS ECMO MACHINE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 15: ASIA-PACIFIC: ARTERIOVENOUS ECMO MACHINE MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 16: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 17: ECMO MACHINE MARKET SIZE FOR RESPIRATORY APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: NORTH AMERICA: ECMO MACHINE MARKET SIZE FOR RESPIRATORY APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 19: EUROPE: ECMO MACHINE MARKET SIZE FOR RESPIRATORY APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: ASIA-PACIFIC: ECMO MACHINE MARKET SIZE FOR RESPIRATORY APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: ECMO MACHINE MARKET SIZE FOR RESPIRATORY APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 22: NEONATES RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS
  • TABLE 23: PEDIATRIC PATIENTS RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS
  • TABLE 24: LUNG TRANSPLANTS IN ADULTS (BETWEEN JANUARY 1995 AND JUNE 2015)
  • TABLE 25: ADULTS RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS
  • TABLE 26: ECMO MACHINE MARKET SIZE FOR CARDIAC APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: NORTH AMERICA: ECMO MACHINE MARKET SIZE FOR CARDIAC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: EUROPE: ECMO MACHINE MARKET FOR CARDIAC APPLICATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 29: ASIA-PACIFIC: ECMO MACHINE MARKET SIZE FOR CARDIAC APPLICATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 30: ECMO MACHINE MARKET SIZE FOR CARDIAC APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 31: ADULTS RECEIVING ECMO SUPPORT FOR CARDIAC APPLICATIONS
  • TABLE 32: PEDIATRIC PATIENTS RECEIVING ECMO SUPPORT FOR CARDIAC APPLICATIONS
  • TABLE 33: NEONATES RECEIVING ECMO SUPPORT FOR CARDIAC APPLICATIONS
  • TABLE 34: ECMO MACHINE MARKET SIZE FOR ECPR APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: ECMO MACHINE MARKET SIZE FOR ECPR APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: EUROPE: ECMO MACHINE MARKET SIZE FOR ECPR APPLICATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 37: ASIA-PACIFIC: ECMO MACHINE MARKET SIZE FOR ECPR APPLICATIONS, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 38: ECMO MARKET SIZE FOR ECPR APPLICATIONS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 39: ECMO MACHINE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: NORTH AMERICA: ECMO MACHINE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: NORTH AMERICA: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 42: NORTH AMERICA: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 43: INDICATIVE LIST OF RESEARCH ARTICLES PUBLISHED IN THE U.S.
  • TABLE 44: U.S.: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 45: U.S.: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 46: CANADA: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 47: CANADA: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: ECMO MACHINE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 51: GERMANY: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 52: GERMANY: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 53: U.K.: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 54: U.K.: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 55: FRANCE: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 56: FRANCE: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 57: ROE: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 58: ROE: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: ECMO MACHINE MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 61: ASIA-PACIFIC: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 62: JAPAN: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 63: JAPAN: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 64: CHINA: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 65: CHINA: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 66: INDICATIVE LIST OF HOSPITALS PROVIDING ECMO TREATMENT
  • TABLE 67: INDIA: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 68: INDIA: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 69: ROAPAC: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 70: ROAPAC: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 71: INDICATIVE LIST OF CONFERENCES RELATED TO ECMO
  • TABLE 72: ROW: ECMO MACHINE MARKET SIZE, BY MODALITY, 2014-2021 (USD MILLION)
  • TABLE 73: ROW: ECMO MACHINE MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 74: APPROVALS, 2013-2016
  • TABLE 75: PRODUCT LAUNCHES, 2013-2016
  • TABLE 76: AGREEMENTS & PARTNERSHIPS, 2013-2016
  • TABLE 77: EXPANSIONS, 2013-2016
  • TABLE 78: OTHER STRATEGIES, 2013-2016

LIST OF FIGURES

  • FIGURE 1: ECMO MACHINE MARKET SEGMENTATION
  • FIGURE 2: EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE MARKET: RESEARCH METHODOLOGY STEPS
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: RESEARCH DESIGN
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: VENOVENOUS SEGMENT DOMINATES THE ECMO MACHINE MARKET, BY MODALITY, IN 2016
  • FIGURE 8: RESPIRATORY APPLICATIONS SEGMENT ACCOUNTS FOR THE LARGEST SHARE OF THE ECMO MACHINE MARKET IN 2016
  • FIGURE 9: ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 10: ASIA-PACIFIC OFFERS SIGNIFICANT GROWTH OPPORTUNITIES FOR PLAYERS IN THE ECMO MACHINE MARKET
  • FIGURE 11: VENOVENOUS SEGMENT IS ESTIMATED TO HAVE DOMINATED THE ECMO MACHINE MARKET IN 2016
  • FIGURE 12: RESPIRATORY APPLICATIONS WILL CONTINUE TO DOMINATE THE ECMO MACHINE MARKET IN 2021
  • FIGURE 13: ASIA-PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
  • FIGURE 14: EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) MACHINE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 15: NUMBER OF DEATHS FROM CARDIOVASCULAR AND RESPIRATORY DISEASES ACROSS THE GLOBE, 2000 VS. 2012 (THOUSAND INDIVIDUALS)
  • FIGURE 16: GLOBAL INCREASE IN THE NUMBER OF ECMO CENTERS
  • FIGURE 17: NORTH AMERICA IS ESTIMATED TO HAVE COMMANDED THE LARGEST SHARE OF THE MARKET IN 2016
  • FIGURE 18: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 19: EUROPE: MARKET SNAPSHOT
  • FIGURE 20: ASIA-PACIFIC: MARKET SNAPSHOT
  • FIGURE 21: REST OF THE WORLD (ROW): MARKET SNAPSHOT
  • FIGURE 22: ECMO MACHINE MARKET SHARE, BY KEY PLAYER, 2015
  • FIGURE 23: KEY DEVELOPMENTS IN THE ECMO MACHINE MARKET, 2013-2016
  • FIGURE 24: BATTLE FOR MARKET SHARE: PRODUCT APPROVALS ACCOUNTED FOR THE LARGEST SHARE OF THE TOTAL DEVELOPMENTS REGISTERED BETWEEN 2013 & 2016
  • FIGURE 25: GEOGRAPHIC REVENUE MIX OF THE PROMINENT PLAYERS IN THE ECMO MACHINE MARKET
  • FIGURE 26: GETINGE GROUP: COMPANY SNAPSHOT (2015) 98  
  • FIGURE 27: MEDTRONIC PLC: COMPANY SNAPSHOT (2015)
  • FIGURE 28: LIVANOVA PLC: COMPANY SNAPSHOT (2014)
  • FIGURE 29: TERUMO CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 30: MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2015)
  • FIGURE 31: NIPRO CORPORATION: COMPANY SNAPSHOT (2015)
Back to Top